Hepatic STAT1-nuclear translocation and interleukin 28B polymorphisms predict treatment outcomes in hepatitis C virus genotype 1-infected patients.

Hepatic STAT1-nuclear translocation and interleukin 28B polymorphisms predict treatment outcomes in hepatitis C virus genotype 1-infected patients.

Item
http://www.wikidata.org/entity/Q34103218
Hepatitis C virus protease inhibitor-resistance mutations: our experience and reviewMeta-analysis: implications of interleukin-28B polymorphisms in spontaneous and treatment-related clearance for patients with hepatitis C.No correlation between PNPLA3 rs738409 genotype and fatty liver and hepatic cirrhosis in Japanese patients with HCVImpact of IL28B genetic variation on HCV-induced liver fibrosis, inflammation, and steatosis: a meta-analysis.Is the use of IL28B genotype justified in the era of interferon-free treatments for hepatitis C?Roles of ITPA and IL28B genotypes in chronic hepatitis C patients treated with peginterferon plus ribavirin.Host genetic variants in the pathogenesis of hepatitis C.Peginterferon Alfa-2a plus ribavirin in Japanese patients infected with hepatitis C virus genotype 2 who failed previous interferon therapy.Sustained Virologic Response at 24 Weeks after the End of Treatment Is a Better Predictor for Treatment Outcome in Real-World HCV-Infected Patients Treated by HCV NS3/4A Protease Inhibitors with Peginterferon plus RibavirinAlanine aminotransferase elevation during peginterferon alpha-2a or alpha-2b plus ribavirin treatmentIL-28B polymorphisms and treatment response in hepatitis C virus patients with persistently normal alanine aminotransferase.IFN-λ gene polymorphisms as predictive factors in chronic hepatitis C treatment-naive patients without access to protease inhibitors.Treatment of hepatitis C virus infection in the future.Coexpression Analysis of Transcriptome on AIDS and Other Human Disease Pathways by Canonical Correlation Analysis.IFNL4 ss469415590 Variant Is Associated with Treatment Response in Japanese HCV Genotype 1 Infected Individuals Treated with IFN-Including Regimens.Effect of discounting on estimation of benefits determined by hepatitis C treatment.
P2860

Hepatic STAT1-nuclear translocation and interleukin 28B polymorphisms predict treatment outcomes in hepatitis C virus genotype 1-infected patients.

Item
http://www.wikidata.org/entity/Q34103218
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Hepatic STAT1-nuclear transloc ...... genotype 1-infected patients.
@ast
Hepatic STAT1-nuclear transloc ...... genotype 1-infected patients.
@en
Hepatic STAT1-nuclear transloc ...... genotype 1-infected patients.
@nl
type
label
Hepatic STAT1-nuclear transloc ...... genotype 1-infected patients.
@ast
Hepatic STAT1-nuclear transloc ...... genotype 1-infected patients.
@en
Hepatic STAT1-nuclear transloc ...... genotype 1-infected patients.
@nl
prefLabel
Hepatic STAT1-nuclear transloc ...... genotype 1-infected patients.
@ast
Hepatic STAT1-nuclear transloc ...... genotype 1-infected patients.
@en
Hepatic STAT1-nuclear transloc ...... genotype 1-infected patients.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Hepatic STAT1-nuclear transloc ...... genotype 1-infected patients.
@en
P2093
P2860
P304
P31
P356
10.1371/JOURNAL.PONE.0028617
P407
P433
P478
P577
P5875
P698
P932